IAM · Iambic Therapeutics, Inc. · Exempt Offerings
Market Cap
$823.35M
Shares
47.40M
Volume · Oct 19
2.39M
Avg daily vol (3 sessions)
2.46M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-09-09 | New | Biotechnology | $66,500,000 | $65,965,000 | 06b |
| 2026-04-08 | New | Biotechnology | $49,999,996 | $27,769,668 | 06b |
| 2025-11-21 | New | Biotechnology | $124,999,970 | $99,269,270 | 06b |
| 2024-06-06 | Amendment | Biotechnology | $49,999,998 | $38,383,040 | 06b |
| 2024-05-07 | Amendment | Biotechnology | $37,999,999 | $29,858,043 | 06b |
| 2024-04-25 | New | Biotechnology | $37,999,999 | $26,874,991 | 06b |
| 2023-10-12 | New | Biotechnology | $109,999,999 | $103,230,763 | 06b |
Showing 1–7 of 7 filings